MAP2 and Alzheimer disease: First, we quantitatively evaluated the aggregates’ properties from confocal images in two independent experiments where the cells were inoculated with AD-tau cases and observed for 14 days and then stained for aggregated mouse tau and dendritic marker MAP2 (Fig. 3A).